Supplements · Metabolic & Cardiometabolic

green tea improves glycemic control

In plain terms: Does green tea lower blood sugar?

Leans support Supplements 🔬 Includes disconfirming🔎 Limited evidence — fewer than 12 studies

RefutedContestedStrong support

consensus score 0.25

Mixed and small. Diabetes trials are split — about half find nothing, half find a tiny fasting-glucose drop. A large population study links tea to less diabetes, but mostly because tea drinkers weigh less. Not a reliable blood-sugar tool.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

6 support 3 contradict 1 tested null 1 mixed · 11 sources, 9 independent groups

What the evidence shows

Genuinely mixed. Meta-analyses of diabetes trials split roughly evenly — several find no significant effect on fasting glucose or HbA1c, a couple find a small fasting-glucose reduction (~1.4 mg/dL). A large UK Biobank cohort links tea to ~14% lower diabetes risk, but that's general tea, observational, and mostly explained by lower body weight.

The evidence (11)

Source	Grade	Stance	Quality	Finding
Alves Ferreira M et al. 2017 · Clin Nutr ESPEN	RCT	supports	moderate	RCT n=120 (overweight women): green tea extract FBG -4.4 mg/dL; nullified when combined with metformin.
Jia Y et al. 2024 · Medicine (Baltimore)	meta-analysis	supports	low	Meta 15 RCTs (T2D): improved fasting glucose (SMD -0.41), HbA1c (SMD -0.68), HOMA-IR (SMD -0.70).
Liu K et al. 2013 · Am J Clin Nutr	meta-analysis	supports	high	Meta 17 RCTs (n=1133): FBG -0.09 mmol/L, HbA1c -0.30%.
Zheng XX et al. 2013 · Am J Clin Nutr	meta-analysis	mixed	high	Meta 22 RCTs (n=1584): FBG -1.48 mg/dL but NO HbA1c/insulin/HOMA-IR effect; glucose effect only >=12 wk.
Yu J et al. 2017 · Diabetes Metab J	meta-analysis	contradicts	moderate	Meta 6 RCTs (prediabetes/T2D): no significant HbA1c, HOMA-IR, insulin, or fasting-glucose difference vs placebo.
Gan Y et al. 2025 · J Am Nutr Assoc	observational	supports	high	UK Biobank (n=382,946, 14 y): 4-5 cups/d tea - 14% lower T2D risk (HR 0.86), partly mediated by BMI (general tea, not green-specific).
Saadh MJ et al. 2025 · Clin Ther	meta-analysis	supports	high	Meta 41 RCTs: EGCG lowered HbA1c -0.18%, FBG/HOMA-IR modestly; authors: likely not clinically meaningful.
Xu R et al. 2020 · Nutr Metab (Lond)	meta-analysis	supports	moderate	Meta 27 RCTs (n=2,194): fasting glucose -1.44 mg/dL (p<.001); no significant HbA1c or insulin effect.
Li Y et al. 2016 · Diabetes Metab Res Rev	meta-analysis	contradicts	moderate	Meta 10 RCTs (T2D): preserved fasting insulin but no significant fasting-glucose or HOMA-IR effect.
Hsu CH et al. 2011 · Altern Med Rev	RCT	tested-null	moderate	RCT n=68 (obese T2D): decaf GTE 856 mg EGCG/16 wk - no between-group HbA1c/HOMA-IR/FBG difference.
Asbaghi O et al. 2021 · Diabetes Metab Syndr	meta-analysis	contradicts	moderate	Meta 14 RCTs (T2D): NO significant effect on fasting glucose, insulin, HbA1c, or HOMA-IR.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.